Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06748911 · ClinicalTrials.gov registry record · NA
Navicam for Detection of Barrett's Esophagus
A NA study of Barrett's Esophagus, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 57
- Enrollment target
- 1
- Study location
NCT06748911 is a NA study of Barrett's Esophagus that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 57 participants, below the 522-participant average among 22 other Barrett's Esophagus trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06748911, a NA study of Barrett's Esophagus, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 57 participants
- Enrollment target
- 1
- Study location
Study Summary
Using a non-invasive capsule system to achieve optimal viewing angles of the esophagus for detection of Barrett's esophagus
Conditions Studied
Interventions
- DEVICE NaviCam Detachable String Capsule
Study Locations (1)
Florida
- Mayo Clinic in Florida - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2025-02-20 |
| Est. Completion | 2026-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06748911
The ClinicalTrials.gov registry entry for NCT06748911 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 522-participant average among 22 other Barrett's Esophagus trials with a reported enrollment target (89% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Barrett's Esophagus appearing as the primary indexed condition, and to 1 intervention - of which NaviCam Detachable String Capsule is the first listed.
NCT06748911 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT06748911 about?
NCT06748911 is a clinical study titled "Navicam for Detection of Barrett's Esophagus". Using a non-invasive capsule system to achieve optimal viewing angles of the esophagus for detection of Barrett's esophagus
What is the current status of trial NCT06748911?
This trial is currently recruiting. It is a NA study. The enrollment target is 57 participants. The study started on 2025-02-20. Estimated completion is 2026-05.
What conditions does trial NCT06748911 study?
This clinical trial studies the following conditions: Barrett's Esophagus.
What interventions are being tested in trial NCT06748911?
The interventions under investigation include: NaviCam Detachable String Capsule (DEVICE).
Who is sponsoring clinical trial NCT06748911?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06748911 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Barrett's Esophagus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pilot Study for TCE Imaging of the Esophagus Using an OFDI Capsule With a Compact Imaging System
RECRUITING · NA
-
Surveillance and Image-Guided Biopsy of the Esophagus Using an OFDI Capsule
ACTIVE NOT RECRUITING · NA
-
Optical Coherence Tomography (OCT) Based Screening of Esophagus and Gastroesophageal Junction
COMPLETED · NA
-
Trial to Assess the Effects of an Antimicrobial Mouthwash on the Esophageal Microbiome
COMPLETED · NA
-
Comparison of Treatments for Barrett's Esophagus With High-Grade Dysplasia/Early Adenocarcinoma
COMPLETED · NA
-
Progression of Gastroesophageal Reflux Disease and Barrett's Esophagus and the Creation of a Barrett's Registry
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.